123 related articles for article (PubMed ID: 15887952)
1. Structure-based virtual screening for plant-based ERbeta-selective ligands as potential preventative therapy against age-related neurodegenerative diseases.
Zhao L; Brinton RD
J Med Chem; 2005 May; 48(10):3463-6. PubMed ID: 15887952
[TBL] [Abstract][Full Text] [Related]
2. Structure-based design of estrogen receptor-beta selective ligands.
Manas ES; Unwalla RJ; Xu ZB; Malamas MS; Miller CP; Harris HA; Hsiao C; Akopian T; Hum WT; Malakian K; Wolfrom S; Bapat A; Bhat RA; Stahl ML; Somers WS; Alvarez JC
J Am Chem Soc; 2004 Nov; 126(46):15106-19. PubMed ID: 15548008
[TBL] [Abstract][Full Text] [Related]
3. Insights into ligand selectivity in estrogen receptor isoforms: molecular dynamics simulations and binding free energy calculations.
Zeng J; Li W; Zhao Y; Liu G; Tang Y; Jiang H
J Phys Chem B; 2008 Mar; 112(9):2719-26. PubMed ID: 18266357
[TBL] [Abstract][Full Text] [Related]
4. Target specific virtual screening: optimization of an estrogen receptor screening platform.
Knox AJ; Meegan MJ; Sobolev V; Frost D; Zisterer DM; Williams DC; Lloyd DG
J Med Chem; 2007 Nov; 50(22):5301-10. PubMed ID: 17918820
[TBL] [Abstract][Full Text] [Related]
5. Computational insights into the mechanism of ligand unbinding and selectivity of estrogen receptors.
Shen J; Li W; Liu G; Tang Y; Jiang H
J Phys Chem B; 2009 Jul; 113(30):10436-44. PubMed ID: 19583238
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterization of 3-arylquinazolinone and 3-arylquinazolinethione derivatives as selective estrogen receptor beta modulators.
Güngör T; Chen Y; Golla R; Ma Z; Corte JR; Northrop JP; Bin B; Dickson JK; Stouch T; Zhou R; Johnson SE; Seethala R; Feyen JH
J Med Chem; 2006 Apr; 49(8):2440-55. PubMed ID: 16610787
[TBL] [Abstract][Full Text] [Related]
7. Subtle side-chain modifications of the hop phytoestrogen 8-prenylnaringenin result in distinct agonist/antagonist activity profiles for estrogen receptors alpha and beta.
Roelens F; Heldring N; Dhooge W; Bengtsson M; Comhaire F; Gustafsson JA; Treuter E; De Keukeleire D
J Med Chem; 2006 Dec; 49(25):7357-65. PubMed ID: 17149865
[TBL] [Abstract][Full Text] [Related]
8. Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity.
Compton DR; Sheng S; Carlson KE; Rebacz NA; Lee IY; Katzenellenbogen BS; Katzenellenbogen JA
J Med Chem; 2004 Nov; 47(24):5872-93. PubMed ID: 15537344
[TBL] [Abstract][Full Text] [Related]
9. Use of binding energy in comparative molecular field analysis of isoform selective estrogen receptor ligands.
Wolohan P; Reichert DE
J Mol Graph Model; 2004 Sep; 23(1):23-38. PubMed ID: 15331051
[TBL] [Abstract][Full Text] [Related]
10. Isocoumarins as estrogen receptor beta selective ligands: Isomers of isoflavone phytoestrogens and their metabolites.
De Angelis M; Stossi F; Waibel M; Katzenellenbogen BS; Katzenellenbogen JA
Bioorg Med Chem; 2005 Dec; 13(23):6529-42. PubMed ID: 16099659
[TBL] [Abstract][Full Text] [Related]
11. Structure-based quantitative structure--activity relationship modeling of estrogen receptor β-ligands.
Dong X; Hilliard SG; Zheng W
Future Med Chem; 2011 Jun; 3(8):933-45. PubMed ID: 21707397
[TBL] [Abstract][Full Text] [Related]
12. Benzopyrans are selective estrogen receptor beta agonists with novel activity in models of benign prostatic hyperplasia.
Norman BH; Dodge JA; Richardson TI; Borromeo PS; Lugar CW; Jones SA; Chen K; Wang Y; Durst GL; Barr RJ; Montrose-Rafizadeh C; Osborne HE; Amos RM; Guo S; Boodhoo A; Krishnan V
J Med Chem; 2006 Oct; 49(21):6155-7. PubMed ID: 17034120
[TBL] [Abstract][Full Text] [Related]
13. Discovery of potent ligands for estrogen receptor beta by structure-based virtual screening.
Shen J; Tan C; Zhang Y; Li X; Li W; Huang J; Shen X; Tang Y
J Med Chem; 2010 Jul; 53(14):5361-5. PubMed ID: 20553023
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
[TBL] [Abstract][Full Text] [Related]
15. Identification of the structural requirements of the receptor-binding affinity of diphenolic azoles to estrogen receptors alpha and beta by three-dimensional quantitative structure-activity relationship and structure-activity relationship analysis.
Demyttenaere-Kovatcheva A; Cronin MT; Benfenati E; Roncaglioni A; Lopiparo E
J Med Chem; 2005 Dec; 48(24):7628-36. PubMed ID: 16302803
[TBL] [Abstract][Full Text] [Related]
16. 6H-Benzo[c]chromen-6-one derivatives as selective ERbeta agonists.
Sun W; Cama LD; Birzin ET; Warrier S; Locco L; Mosley R; Hammond ML; Rohrer SP
Bioorg Med Chem Lett; 2006 Mar; 16(6):1468-72. PubMed ID: 16412638
[TBL] [Abstract][Full Text] [Related]
17. The discovery of tetrahydrofluorenones as a new class of estrogen receptor beta-subtype selective ligands.
Wilkening RR; Ratcliffe RW; Tynebor EC; Wildonger KJ; Fried AK; Hammond ML; Mosley RT; Fitzgerald PM; Sharma N; McKeever BM; Nilsson S; Carlquist M; Thorsell A; Locco L; Katz R; Frisch K; Birzin ET; Wilkinson HA; Mitra S; Cai S; Hayes EC; Schaeffer JM; Rohrer SP
Bioorg Med Chem Lett; 2006 Jul; 16(13):3489-94. PubMed ID: 16632357
[TBL] [Abstract][Full Text] [Related]
18. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 4: functionalization of the benzopyran A-ring.
Norman BH; Richardson TI; Dodge JA; Pfeifer LA; Durst GL; Wang Y; Durbin JD; Krishnan V; Dinn SR; Liu S; Reilly JE; Ryter KT
Bioorg Med Chem Lett; 2007 Sep; 17(18):5082-5. PubMed ID: 17662603
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of anthranylaldoxime derivatives as estrogen receptor ligands and computational prediction of binding modes.
Tuccinardi T; Bertini S; Martinelli A; Minutolo F; Ortore G; Placanica G; Prota G; Rapposelli S; Carlson KE; Katzenellenbogen JA; Macchia M
J Med Chem; 2006 Aug; 49(16):5001-12. PubMed ID: 16884312
[TBL] [Abstract][Full Text] [Related]
20. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 2: structure-activity relationship studies on the benzopyran scaffold.
Richardson TI; Norman BH; Lugar CW; Jones SA; Wang Y; Durbin JD; Krishnan V; Dodge JA
Bioorg Med Chem Lett; 2007 Jul; 17(13):3570-4. PubMed ID: 17485205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
